-transparent.png){kind=logo}
Immune hemolytic anemia and chronic active hepatitis developed concurrently in a 76-year-old man after prolonged therapy with methyldopa. Both complications disappeared following cessation of treatment with the offending drug and a short course of a high-dose corticosteroid (prednisone). Inhibition of T-suppressor lymphocyte function by methyldopa may be instrumental in the emergence of autoimmune complications following usage of the drug.
Related Publications
O Shalev, and
M Mosseri, and
I Ariel, and
R Stalnikowicz
November 1975,
The West Virginia medical journal,
O Shalev, and
M Mosseri, and
I Ariel, and
R Stalnikowicz
June 1982,
Drug intelligence & clinical pharmacy,
O Shalev, and
M Mosseri, and
I Ariel, and
R Stalnikowicz
July 1994,
Israel journal of medical sciences,
O Shalev, and
M Mosseri, and
I Ariel, and
R Stalnikowicz
June 1971,
Boletin de la Asociacion Medica de Puerto Rico,
O Shalev, and
M Mosseri, and
I Ariel, and
R Stalnikowicz
February 1970,
New York state journal of medicine,
O Shalev, and
M Mosseri, and
I Ariel, and
R Stalnikowicz
October 1966,
Lancet (London, England),
O Shalev, and
M Mosseri, and
I Ariel, and
R Stalnikowicz
January 1979,
Archivos del Instituto de Cardiologia de Mexico,
O Shalev, and
M Mosseri, and
I Ariel, and
R Stalnikowicz
February 1982,
Harefuah,
O Shalev, and
M Mosseri, and
I Ariel, and
R Stalnikowicz
January 1978,
Nederlands tijdschrift voor geneeskunde,
O Shalev, and
M Mosseri, and
I Ariel, and
R Stalnikowicz
December 1973,
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
